COVID-19 Vaccine.
作者信息
Fernandes Amanda, Chaudhari Sonya, Jamil Nadia, Gopalakrishnan Geetha
机构信息
Alpert Medical School of Brown University, Providence, Rhode Island.
Alpert Medical School of Brown University, Providence, Rhode Island.
出版信息
Endocr Pract. 2021 Feb;27(2):170-172. doi: 10.1016/j.eprac.2021.01.013. Epub 2021 Jan 27.
Abstract
摘要
相似文献
1
COVID-19 Vaccine.新冠疫苗
Endocr Pract. 2021 Feb;27(2):170-172. doi: 10.1016/j.eprac.2021.01.013. Epub 2021 Jan 27.
2
A global survey of potential acceptance of a COVID-19 vaccine.一项针对 COVID-19 疫苗潜在接受度的全球调查。
Nat Med. 2021 Feb;27(2):225-228. doi: 10.1038/s41591-020-1124-9. Epub 2020 Oct 20.
3
High but slightly declining COVID-19 vaccine acceptance and reasons for vaccine acceptance, Finland April to December 2020.2020 年 4 月至 12 月芬兰：高但略有下降的 COVID-19 疫苗接受率及其原因。
Epidemiol Infect. 2021 May 11;149:e123. doi: 10.1017/S0950268821001114.
4
Willingness to vaccinate against COVID-19 in Australia.澳大利亚民众接种新冠疫苗的意愿。
Lancet Infect Dis. 2021 Mar;21(3):318-319. doi: 10.1016/S1473-3099(20)30559-4. Epub 2020 Jun 30.
5
Acceptance of coronavirus disease 2019 vaccine among health-care personnel in India: a cross-sectional survey during the initial phase of vaccination.印度医护人员对2019冠状病毒病疫苗的接受情况：疫苗接种初始阶段的横断面调查
Clin Microbiol Infect. 2021 Jul;27(7):1064-1066. doi: 10.1016/j.cmi.2021.03.008. Epub 2021 Mar 31.
6
COVID-19 Vaccine: Promoting Vaccine Acceptance.新型冠状病毒肺炎疫苗：促进疫苗接种。
Ann Intern Med. 2021 Feb;174(2):252-253. doi: 10.7326/M20-8008. Epub 2020 Dec 21.
7
SARS-CoV-2 vaccine hesitancy among patients with rheumatic and musculoskeletal diseases: a message for rheumatologists.风湿性和肌肉骨骼疾病患者对新型冠状病毒2型疫苗的犹豫态度：给风湿病学家的启示
Ann Rheum Dis. 2021 Jul;80(7):953-954. doi: 10.1136/annrheumdis-2021-220059. Epub 2021 Feb 23.
8
COVID-19 vaccines, hesitancy and mental health.2019冠状病毒病疫苗、犹豫态度与心理健康
Evid Based Ment Health. 2021 May;24(2):47-48. doi: 10.1136/ebmental-2021-300266. Epub 2021 Apr 13.
9
Acceptance of COVID-19 vaccine in Pakistan among health care workers.巴基斯坦医护人员对 COVID-19 疫苗的接受度。
PLoS One. 2021 Sep 15;16(9):e0257237. doi: 10.1371/journal.pone.0257237. eCollection 2021.
10
Modification of a vaccine hesitancy scale for use in adult vaccinations in the United States and China.疫苗犹豫量表的修订版，用于美国和中国的成人疫苗接种。
Hum Vaccin Immunother. 2021 Aug 3;17(8):2639-2646. doi: 10.1080/21645515.2021.1884476. Epub 2021 Mar 26.
引用本文的文献
1
Geographical and practical challenges in the implementation of digital health passports for cross-border COVID-19 pandemic management: a narrative review and framework for solutions.地理和实际挑战在数字健康护照的实施跨境 COVID-19 大流行管理:叙事审查和解决方案的框架。
Global Health. 2023 Dec 8;19(1):98. doi: 10.1186/s12992-023-00998-7.
2
Tracking trends in COVID-19 vaccines based on 47 different vaccines: A bibliometric review.基于 47 种不同疫苗追踪 COVID-19 疫苗趋势：文献计量学综述。
Hum Vaccin Immunother. 2023 Aug 1;19(2):2242747. doi: 10.1080/21645515.2023.2242747.
3
Implications for COVID-19 vaccine uptake: A systematic review.对 COVID-19 疫苗接种的影响：系统评价。
J Infect Public Health. 2023 Mar;16(3):441-466. doi: 10.1016/j.jiph.2023.01.020. Epub 2023 Jan 30.
4
Multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) following COVID-19 vaccines: A systematic review.新冠病毒疫苗接种后多发性硬化症 (MS) 和视神经脊髓炎谱系障碍 (NMOSD)：系统评价。
Rev Neurol (Paris). 2023 Apr;179(4):265-281. doi: 10.1016/j.neurol.2022.11.004. Epub 2023 Jan 17.
5
Antiviral Effects of Heparan Sulfate Analogue-Modified Two-Dimensional MXene Nanocomposites on PRRSV and SARS-CoV-2.硫酸乙酰肝素类似物修饰的二维MXene纳米复合材料对猪繁殖与呼吸综合征病毒和严重急性呼吸综合征冠状病毒2的抗病毒作用
Adv Nanobiomed Res. 2022 Oct;2(10):2200067. doi: 10.1002/anbr.202200067. Epub 2022 Aug 15.
6
A Review of Different Vaccines and Strategies to Combat COVID-19.抗击新冠病毒的不同疫苗及策略综述
Vaccines (Basel). 2022 May 9;10(5):737. doi: 10.3390/vaccines10050737.
7
Bone Marrow Suppression Secondary to the COVID-19 Booster Vaccine: A Case Report.新型冠状病毒肺炎加强疫苗接种继发的骨髓抑制：一例报告
J Blood Med. 2022 Feb 18;13:69-74. doi: 10.2147/JBM.S350290. eCollection 2022.
8
A comprehensive review on efficient approaches for combating coronaviruses.关于对抗冠状病毒的有效方法的综合综述。
Biomed Pharmacother. 2021 Dec;144:112353. doi: 10.1016/j.biopha.2021.112353. Epub 2021 Oct 22.
9
Coronavirus disease 2019 (Covid-19) vaccination recommendations in special populations and patients with existing comorbidities.新型冠状病毒病 2019（COVID-19）疫苗在特殊人群和合并症患者中的接种建议。
Rev Med Virol. 2022 May;32(3):e2309. doi: 10.1002/rmv.2309. Epub 2021 Oct 22.
10
Cold atmospheric plasma: A non-negligible strategy for viral RNA inactivation to prevent SARS-CoV-2 environmental transmission.冷大气等离子体：一种不可忽视的用于病毒RNA失活以预防SARS-CoV-2环境传播的策略。
AIP Adv. 2021 Aug 10;11(8):085019. doi: 10.1063/5.0060530. eCollection 2021 Aug.
本文引用的文献
1
Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera.BNT162b2 疫苗诱导的血清对 SARS-CoV-2 刺突 69/70 缺失、E484K 和 N501Y 变异株的中和作用。
Nat Med. 2021 Apr;27(4):620-621. doi: 10.1038/s41591-021-01270-4. Epub 2021 Feb 8.
2
Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Moderna COVID-19 Vaccine - United States, December 21, 2020-January 10, 2021.美国 2020 年 12 月 21 日-2021 年 1 月 10 日期间，在接种 Moderna COVID-19 疫苗第一针后出现过敏反应（包括过敏反应）。
MMWR Morb Mortal Wkly Rep. 2021 Jan 29;70(4):125-129. doi: 10.15585/mmwr.mm7004e1.
3
Interim Results of a Phase 1-2a Trial of Ad26.COV2.S Covid-19 Vaccine.Ad26.COV2.S 新冠疫苗 1/2a 期临床试验的中期结果。
N Engl J Med. 2021 May 13;384(19):1824-1835. doi: 10.1056/NEJMoa2034201. Epub 2021 Jan 13.
4
SARS-CoV-2 Transmission From People Without COVID-19 Symptoms.SARS-CoV-2 从无 COVID-19 症状者传播。
JAMA Netw Open. 2021 Jan 4;4(1):e2035057. doi: 10.1001/jamanetworkopen.2020.35057.
5
Beyond Politics - Promoting Covid-19 Vaccination in the United States.超越政治——在美国推广新冠疫苗接种
N Engl J Med. 2021 Feb 18;384(7):e23. doi: 10.1056/NEJMms2033790. Epub 2021 Jan 6.
6
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.mRNA-1273 新型冠状病毒疫苗的有效性和安全性。
N Engl J Med. 2021 Feb 4;384(5):403-416. doi: 10.1056/NEJMoa2035389. Epub 2020 Dec 30.
7
Maintaining Safety with SARS-CoV-2 Vaccines.通过新冠病毒疫苗维持安全性。
N Engl J Med. 2021 Feb 18;384(7):643-649. doi: 10.1056/NEJMra2035343. Epub 2020 Dec 30.
8
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.ChAdOx1 nCoV-19 疫苗（阿斯利康）对 SARS-CoV-2 的安全性和有效性：巴西、南非和英国四项随机对照试验的中期分析。
Lancet. 2021 Jan 9;397(10269):99-111. doi: 10.1016/S0140-6736(20)32661-1. Epub 2020 Dec 8.
9
The granting of emergency use designation to COVID-19 candidate vaccines: implications for COVID-19 vaccine trials.赋予 COVID-19 候选疫苗紧急使用授权：对 COVID-19 疫苗试验的影响。
Lancet Infect Dis. 2021 Apr;21(4):e103-e109. doi: 10.1016/S1473-3099(20)30923-3. Epub 2020 Dec 8.
10
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.BNT162b2 mRNA 新冠病毒疫苗的安全性和有效性。
N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub 2020 Dec 10.
Zotero 插件